Pasternak Richard C 4
4 · Milestone Pharmaceuticals Inc. · Filed Oct 21, 2022
Insider Transaction Report
Form 4
Pasternak Richard C
Director
Transactions
- Purchase
Common Shares
2022-10-20$5.20/sh+10,000$52,000→ 10,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.24 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.